Should we reconsider the routine use of placebo controls in clinical research?
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Modern clinical-research practice favors placebo controls over usual-care controls whenever a credible placebo exists. An unrecognized consequence of this preference is that clinicians are more limited in their ability to provide the benefits of the non-specific healing effects of placebos in clinical practice. METHODS: We examined the issues in choosing between placebo and usual-care controls. We considered why placebo controls place constraints on clinicians and the trade-offs involved in the choice of control groups. RESULTS: We find that, for certain studies, investigators should consider usual-care controls, even if an adequate placebo is available. Employing usual-care controls would be of greatest value for pragmatic trials evaluating treatments to improve clinical care and for which threats to internal validity can be adequately managed without a placebo-control condition. CONCLUSIONS: Intentionally choosing usual-care controls, even when a satisfactory placebo exists, would allow clinicians to capture the value of non-specific therapeutic benefits that are common to all interventions. The result could be more effective, patient-centered care that makes the best use of both specific and non-specific benefits of medical interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Explanatory and pragmatic attitudes in therapeutical trials
Schwartz, D., & Lellouch, J. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90041-0 · Cited by 1,185 · cited 3×
“On the other hand, if the primary intent is to study the value of an intervention for improving the lives of patients (that is, a ‘pragmatic trial’ [14]), then a usual-care control group may, in some circumstances, be preferable, as it would incorporate both biologic and non-specific placebo benefits for patients.”
BackgroundInfluentialPlacebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900 · cited 1×
“However, many authorities contend that the deliberate use of placebos runs counter to modern clinical ethics since it requires deceiving patients by leading them to believe that the placebo has specific biologic activity that it does not possess [10-12] (though recent data suggest that deception might not be essential…”
BackgroundPlacebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465
Placebo effects: clinical aspects and neurobiology
Oken, B. S. (2008) · Brain · doi:10.1093/brain/awn116 · Cited by 237 · cited 1×
“Numerous direct studies of placebo effects confirm that placebos can induce physiologic changes that result in beneficial effects for patients [5,6].”
BackgroundPlacebo effect studies are susceptible to response bias and to other types of biases
Hróbjartsson, A., Kaptchuk, T. J., & Miller, F. G. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.008 · Cited by 150 · cited 1×
“Clinical research is vulnerable to measurement and reporting bias [23].”
BackgroundWhy use placebos in clinical trials? A narrative review of the methodological literature
Vickers, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00139-0 · Cited by 121 · cited 2×
“However, in trials conducted primarily to identify ways to improve patients’ quality of life, we should reconsider our instinctive tendency to employ a placebo control whenever possible [17].”
Background
Cited by
Kubo, A., Kurtovich, E., McGinnis, M., Aghaee, S., Altschuler, A., Quesenberry, C., Kolevska, T., & Avins, A. L. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419850634 · Cited by 167
Self-citationControl Group Design: Enhancing Rigor in Research of Mind-Body Therapies for Depression
Kinser, P. A., & Robins, J. L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/140467 · Cited by 155
Bishop, F. L., Fenge-Davies, A. L., Kirby, S., & Geraghty, A. W. A. (2015) · Psychology & Health · doi:10.1080/08870446.2014.953529 · Cited by 121
Kubo, A., Kurtovich, E., McGinnis, M., Aghaee, S., Altschuler, A., Quesenberry, C., Kolevska, T., Liu, R., Greyz‐Yusupov, N., & Avins, A. (2024) · Psycho-Oncology · doi:10.1002/pon.5557 · Cited by 57
Self-citationHarris, R. G., Neale, E. P., & Ferreira, I. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz071 · Cited by 38
Metadata
- Authors
- Avins, A. L., Cherkin, D. C., Sherman, K. J., Goldberg, H., & Pressman, A.
- Venue
- Trials
- Published
- 2012-04-27
- Volume
- 13
- Issue
- 1
- Pages
- 44-44
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W2155264757
- Cited by
- 43
- References
- 6
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Should we reconsider the routine use of placebo controls in clinical research? https://app.cochat.ai/papers/10.1186/1745-6215-13-44
- The paper
- Avins, A. L., Cherkin, D. C., Sherman, K. J., Goldberg, H., & Pressman, A. (2012). Should we reconsider the routine use of placebo controls in clinical research? Trials. https://doi.org/10.1186/1745-6215-13-44
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.